BAPEL

Value-based pricing of new medicines with the advanced
pharmacoeconomic modeling technologies

Generating real-world evidence (RWE) from healthcare big data with
advanced statistical methodology

Measuring patient-reported outcomes including quality of life

Pharmaceutical policy evaluation / Regulatory science

Health outcomes and Health Services research

Synthesizing evidence through systematic review and meta-analysis

Project-based Data Science & Statistical Program Learning

Pharmacoeconomics modeling

Social and Administrative Pharmacy

Pharmacy Ethics, Law, and Regulation

Graduate Program of Regulatory Science and Pharmaceutical Industrial Course